- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Universal Ibogaine Inc: Universal Ibogaine suspended by ASC | 5 | Stockwatch | ||
| Di | XFRA JC4: AUSSETZUNG/SUSPENSION | 79 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIVERSAL IBOGAINE... ► Artikel lesen | |
| 20.01. | Universal Ibogaine Inc: Universal Ibogaine has no material changes | 26 | Stockwatch | ||
| 19.01. | Universal Ibogaine Inc.: Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process | 6 | TheNewswire | ||
| 03.01. | Universal Ibogaine Inc: Universal Ibogaine debt matures; MCTO in effect | 10 | Stockwatch | ||
| 03.01. | Universal Ibogaine Inc.: Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process | 2 | TheNewswire | ||
| UNIVERSAL IBOGAINE Aktie jetzt für 0€ handeln | |||||
| 19.12.25 | Universal Ibogaine Inc.: Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process | 5 | TheNewswire | ||
| 03.12.25 | Universal Ibogaine Inc.: Universal Ibogaine advises further on application for Management Cease Trade Order | 8 | TheNewswire | ||
| 26.11.25 | Universal Ibogaine Inc: Universal Ibogaine applies for MCTO | 8 | Stockwatch | ||
| 25.11.25 | Universal Ibogaine Inc.: Universal Ibogaine Advises of Filing Application for Management Cease Trade Order | 4 | TheNewswire | ||
| 28.10.25 | Universal Ibogaine Inc: Universal Ibogaine "temporarily" closes Kelburn | 19 | Stockwatch | ||
| 28.10.25 | Universal Ibogaine Inc.: Universal Ibogaine Provides Corporate Update | 11 | TheNewswire | ||
| 24.09.25 | Universal Ibogaine Inc: Universal Ibogaine board lists five directors | 32 | Stockwatch | ||
| 23.09.25 | Universal Ibogaine Inc.: Universal Ibogaine Announces Board Changes | 11 | TheNewswire | ||
| 15.09.25 | Universal Ibogaine Inc: Universal Ibogaine shareholders vote down two matters | 4 | Stockwatch | ||
| 15.09.25 | Universal Ibogaine Inc.: Universal Ibogaine Announces Results of the Annual Meeting of Shareholders | 15 | TheNewswire | ||
| 05.09.25 | Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply | 17 | TheNewswire | ||
| 04.09.25 | Universal Ibogaine Inc: Universal Ibogaine adds Killebrew, Wagner as directors | 14 | Stockwatch | ||
| 03.09.25 | Universal Ibogaine Inc.: Universal Ibogaine advises of appointment of two new Board Members | 4 | TheNewswire | ||
| 10.04.25 | XFRA JC4: WIEDERAUFNAHME/RESUMPTION | 383 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 80,49 | +0,05 % | Sanofi und Amgen: Droht diesem Ansatz das Aus? AKTIONÄR-Tipp profitiert! | Viele große Pharma- und Biotech-Firmen sind auf der Suche nach neuen Behandlungsansätzen für die Atopische Dermatitis (Neurodermitis). So auch die großen Branchenvertreter Amgen und Sanofi, die mit... ► Artikel lesen | |
| CANOPY GROWTH | 0,935 | -0,95 % | Canopy Growth: Treffer ohne Gewinn - Trading-Tipp wird zurückgezogen | ||
| ASTRAZENECA | 160,70 | 0,00 % | Erfolg für AstraZeneca | Der Pharmakonzern hat gestern gemeldet, dass sein Medikament Imfinzi in Kombination mit einer Chemotherapie für die Behandlung erwachsener Patienten mit Magen- sowie gastroösophagealen Übergangstumoren... ► Artikel lesen | |
| INNOCAN PHARMA | 4,020 | -3,37 % | INNOCAN PHARMA im Fokus ruhiger Neubewertung | ||
| ZOETIS | 108,12 | +0,30 % | Zoetis Inc. - 8-K, Current Report | ||
| IONIS PHARMACEUTICALS | 71,92 | -1,72 % | Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 6 Analysts | ||
| HAPPY BELLY FOOD GROUP | 1,070 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly's Yolks Breakfast Signs Franchise Agreement and Real-Estate Location in the City of Langley, British Columbia | Toronto, Ontario--(Newsfile Corp. - January 26, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFG) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| CSPC PHARMA | 1,031 | +0,49 % | HSI Closes at 26,834, Up 59 pts; HSTI Closes at 5,467, Down 59 pts; CSPC PHARMA Up over 8%; NEW ORIENTAL, HSBC HOLDINGS, MTR CORPORATION, POWER ASSETS, CIMC Hit New Highs; Market Turnover Rises | ||
| ALTIMMUNE | 4,193 | +1,67 % | Altimmune, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| CATALYST PHARMACEUTICALS | 20,550 | -0,63 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update | Reported Q3 2025 Total Revenues of $148.4 Million, Driven by Continued FIRDAPSE® Growth, Strong AGAMREE® Uptake and Growth, and Continued Demand for FYCOMPA® Raising Full-Year 2025 Total Revenue Guidance... ► Artikel lesen | |
| AVADEL PHARMACEUTICALS | 18,100 | 0,00 % | Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| ELANCO ANIMAL HEALTH | 21,440 | +0,52 % | Elanco: Protein, Science, Debate and Dietary Guidelines: Nina Teicholz | NORTHAMPTON, MA / ACCESS Newswire / January 30, 2026 / By Jeff SimmonsProtein. It's everywhere. From our center of the plate favorites to protein popcorn, ramen to even protein-packed ice cream, it's... ► Artikel lesen | |
| ONO PHARMACEUTICAL | 13,300 | -1,48 % | Ono Pharmaceutical Co. Ltd. Reveals Climb In Nine Months Bottom Line | TOKYO (dpa-AFX) - Ono Pharmaceutical Co. Ltd. (OPHLF) released a profit for its nine months that Increases, from the same period last yearThe company's earnings came in at JPY68.949 billion... ► Artikel lesen | |
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Third Quarter 2025 Financial Results | NEW YORK and TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen |
Das Unternehmen UNIVERSAL IBOGAINE INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,004 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UNIVERSAL IBOGAINE INC finden Sie auf Wallstreet Online.